: AstraZeneca to decarbonize U.S. footprint by turning cow manure into renewable natural gas

In a first for the pharma sector, AstraZeneca will tap renewable natural gas for its U.S. manufacturing sites by the end of 2026.

Previous post Market Extra: ‘Crowded’ tech trade? Investors still haven’t piled into these two big names.
Next post Deep Dive: The bull market has left these 20 companies behind, but they are primed for growth